| 1 |
34534538 | Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance. | 2022 Jan |
1 |
| 2 |
34955688 | Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines. | 2021 |
1 |
| 3 |
30628651 | MicroRNA-200b and -301 are associated with gemcitabine response as biomarkers in pancreatic carcinoma cells. | 2019 Mar |
1 |
| 4 |
31186697 | Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab. | 2019 Jun |
1 |
| 5 |
31760928 | Effect of Chemotherapeutic Agents on the Expression of Retinoid Receptors and Markers of Cancer Stem Cells and Epithelial-Mesenchymal Transition. | 2019 Nov |
1 |
| 6 |
29767267 | HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells. | 2018 Jul |
1 |
| 7 |
28638102 | miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. | 2017 Jun 21 |
1 |
| 8 |
22622284 | Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells. | 2012 Aug |
1 |
| 9 |
20573371 | Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma. | 2010 Sep |
1 |
| 10 |
19584296 | Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. | 2009 Jul 15 |
1 |
| 11 |
19654291 | Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. | 2009 Aug 15 |
1 |
| 12 |
17875687 | Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells. | 2007 Sep 15 |
1 |
| 13 |
17909916 | Development and characterization of gemcitabine-resistant pancreatic tumor cells. | 2007 Dec |
1 |